Relationship between pulsation of posterior vortex vein, choroidal thickness, and choroidal vascular hyperpermeability in polypoidal choroidal vasculopathy.


Journal

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 18 01 2023
accepted: 07 08 2023
revised: 01 08 2023
medline: 27 11 2023
pubmed: 24 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

Posterior vortex vein pulsation on Heidelberg indocyanine green angiography (HRA-IA) video is reported to indicate the presence of congestion in these vessels. This study aimed to determine the relationship between posterior vortex vein pulsation, choroidal thickness, and choroidal vascular hyperpermeability (CVH) in polypoidal choroidal vasculopathy (PCV). Forty-three eyes of 43 patients who had not received previous treatment and were diagnosed with PCV using multimodal imaging were included and retrospectively investigated. On initial visit, presence or absence of pulsation in the posterior vortex vein was analysed using HRA-IA. Subfoveal choroidal thickness (SFCT) was assessed, and patients were divided into the SFCT ≥ 200 μm and < 200 μm (P and NP, respectively) groups. Presence or absence of CVH was investigated using IA in the late phase, and the associations between the three parameters were analysed. Posterior vortex vein pulsation was detected in 24/43 eyes (55%). There were 27 eyes in the P group (mean SFCT, 286 ± 48 μm) and 16 eyes in the NP group (mean SFCT, 143 ± 41 μm). Pulsation was detected in 10 eyes (37%) in the P group and 14 eyes (88%) in the NP group. Incidence of pulsation was significantly higher in the NP group (P < 0.05). There were 17 (40%) patients with CVH-13 (48%) and four (25%) in the P and NP groups, respectively (P = 0.1994). There was no correlation between the presence or absence of pulsation and CVH (P = 0.1994). Congestion of the vortex vein is potentially associated with the pathogenesis of PCV with a thin choroid.

Identifiants

pubmed: 37615698
doi: 10.1007/s00417-023-06203-0
pii: 10.1007/s00417-023-06203-0
doi:

Substances chimiques

Indocyanine Green IX6J1063HV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3475-3480

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Mitchell P, Smith W, Attebo K, Wang JJ (1995) Prevalence of age-related maculopathy in Australia. Blue Mountains Eye Study Ophthalmol 102:1450–1460. https://doi.org/10.1016/s0161-6420(95)30846-9
doi: 10.1016/s0161-6420(95)30846-9
Klein R, Klein BE, Cruickshanks KJ (1999) The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 18:371–389. https://doi.org/10.1016/s1350-9462(98)00025-1
doi: 10.1016/s1350-9462(98)00025-1 pubmed: 10192518
Klaver CC, Assink JJ, van Leeuwen R, Wolfs RC, Vingerling JR, Stijnen T, Hofman A, de Jong PT (2001) Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 42:2237–2241
pubmed: 11527936
Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB, Wang JJ, Mitchell P, Wong TY (2010) The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 117:921–927. https://doi.org/10.1016/j.ophtha.2009.10.007
doi: 10.1016/j.ophtha.2009.10.007 pubmed: 20110127
Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, Gomi F, Koh AH, Lee WK, Wong TY (2018) Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 125:708–724. https://doi.org/10.1016/j.ophtha.2017.11.019
doi: 10.1016/j.ophtha.2017.11.019 pubmed: 29331556
Pang CE, Freund KB (2015) Pachychoroid neovasculopathy. Retina 35:1–9. https://doi.org/10.1097/IAE.0000000000000331
doi: 10.1097/IAE.0000000000000331 pubmed: 25158945
Chung SE, Kang SW, Lee JH, Kim YT (2011) Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 118:840–845. https://doi.org/10.1016/j.ophtha.2010.09.012
doi: 10.1016/j.ophtha.2010.09.012 pubmed: 21211846
Koizumi H, Yamagishi T, Yamazaki T, Kawasaki R, Kinoshita S (2011) Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 249:1123–1128. https://doi.org/10.1007/s00417-011-1620-1
doi: 10.1007/s00417-011-1620-1 pubmed: 21274555
Yanagi Y, Ting DSW, Ng WY, Lee SY, Mathur R, Chan CM, Yeo I, Wong TY, Cheung GCM (2018) Choroidal vascular hyperpermeability as a predictor of treatment response for polypoidal choroidal vasculopathy. Retina 38:1509–1517. https://doi.org/10.1097/IAE.0000000000001758
doi: 10.1097/IAE.0000000000001758 pubmed: 28704255
Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, Yoshimura N (2012) Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 53:3663–3672. https://doi.org/10.1167/iovs.12-9619
doi: 10.1167/iovs.12-9619 pubmed: 22570352
Lee WK, Baek J, Dansingani KK, Lee JH, Freund KB (2016) Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal subfoveal choroidal thickness. Retina 36(Suppl 1):S73–S82. https://doi.org/10.1097/IAE.0000000000001346
doi: 10.1097/IAE.0000000000001346 pubmed: 28005665
Paques M, Baillart O, Genevois O, Gaudric A, Levy BI, Sahel J (2005) Systolodiastolic variations of blood flow during central retinal vein occlusion: exploration by dynamic angiography. Brit J Ophthalmol 89:1036–1040. https://doi.org/10.1136/bjo.2004.061275
doi: 10.1136/bjo.2004.061275
Yamada C, Mukai R, Shinohara Y, Matsumoto H, Akiyama H (2022) Occlusion of a vortex vein after treatment with half-fluence photodynamic therapy combined with intravitreal aflibercept injection for pachychoroid neovasculopathy. Cureus 14:e27663. https://doi.org/10.7759/cureus.27663
doi: 10.7759/cureus.27663 pubmed: 35935116 pmcid: 9352534
Matsumoto H, Hoshino J, Mukai R, Nakamura K, Kishi S, Akiyama H (2021) Pulsation of anastomotic vortex veins in pachychoroid spectrum diseases. Sci Rep 11:14942. https://doi.org/10.1038/s41598-021-94412-0
doi: 10.1038/s41598-021-94412-0 pubmed: 34294774 pmcid: 8298457
Mukai R, Matsumoto H, Miyakubo T, Akiyama H (2021) Reduced vascular density in the choroid after treatment with photodynamic therapy combined with aflibercept in patients with polypoidal choroidal vasculopathy. Retina 41:156–161. https://doi.org/10.1097/IAE.0000000000002793
doi: 10.1097/IAE.0000000000002793 pubmed: 32251239
Hiroe T, Kishi S (2018) Dilatation of asymmetric vortex vein in central serous chorioretinopathy. Ophthalmol Retina 2:152–161. https://doi.org/10.1016/j.oret.2017.05.013
doi: 10.1016/j.oret.2017.05.013 pubmed: 31047342
Gemmy Cheung CM, Teo KYC, Spaide RF (2021) Pulsatile filling of dilated choroidal vessels in macular watershed zones. Retina 41:2370–2377. https://doi.org/10.1097/IAE.0000000000003195
doi: 10.1097/IAE.0000000000003195 pubmed: 34264572
Spaide RF, Gemmy Cheung CM, Matsumoto H, Kishi S, Boon CJF, van Dijk EHC, Mauget-Faysse M, Behar-Cohen F, Hartnett ME, Sivaprasad S, Iida T, Brown DM, Chhablani J, Maloca PM (2022) Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders. Prog Retin Eye Res 86:100973. https://doi.org/10.1016/j.preteyeres.2021.100973
doi: 10.1016/j.preteyeres.2021.100973 pubmed: 34029721
Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, Ueda-Arakawa N, Oishi A, Nakanishi H, Tamura H, Tsujikawa A, Yoshimura N (2015) Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep 5:16204. https://doi.org/10.1038/srep16204
doi: 10.1038/srep16204 pubmed: 26542071 pmcid: 4635432
Chang YC, Cheng CK (2020) Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy. Retina 40:1403–1411. https://doi.org/10.1097/IAE.0000000000002583
doi: 10.1097/IAE.0000000000002583 pubmed: 31181038
Matsumoto H, Mukai R, Saito K, Hoshino J, Kishi S, Akiyama H (2022) Vortex vein congestion in the monkey eye: a possible animal model of pachychoroid. PLoS One 17:e0274137. https://doi.org/10.1371/journal.pone.0274137
doi: 10.1371/journal.pone.0274137 pubmed: 36048858 pmcid: 9436071
Imanaga N, Terao N, Nakamine S, Tamashiro T, Wakugawa S, Sawaguchi K, Koizumi H (2021) Scleral thickness in central serous chorioretinopathy. Ophthalmol Retina 5:285–291. https://doi.org/10.1016/j.oret.2020.07.011
doi: 10.1016/j.oret.2020.07.011 pubmed: 32683110
Takahashi K, Kishi S (2000) Remodeling of choroidal venous drainage after vortex vein occlusion following scleral buckling for retinal detachment. Am J Ophthalmol 129:191–198. https://doi.org/10.1016/s0002-9394(99)00425-0
doi: 10.1016/s0002-9394(99)00425-0 pubmed: 10682972
Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA (1996) Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16:203–213. https://doi.org/10.1097/00006982-199616030-00004
doi: 10.1097/00006982-199616030-00004 pubmed: 8789858
Sasahara M, Tsujikawa A, Musashi K, Gotoh N, Otani A, Mandai M, Yoshimura N (2006) Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 142:601–607. https://doi.org/10.1016/j.ajo.2006.05.051
doi: 10.1016/j.ajo.2006.05.051 pubmed: 17011852
Kang HG, Han JY, Kim M, Byeon SH, Kim SS, Koh HJ, Lee CS (2021) Pachydrusen, choroidal vascular hyperpermeability, and punctate hyperfluorescent spots. Graefes Arch Clin Exp Ophthalmol 259:2391–2400. https://doi.org/10.1007/s00417-021-05180-6
doi: 10.1007/s00417-021-05180-6 pubmed: 33907882
Miyake M, Tsujikawa A, Yamashiro K, Ooto S, Oishi A, Tamura H, Nakata I, Matsuda F, Yoshimura N (2014) Choroidal neovascularization in eyes with choroidal vascular hyperpermeability. Invest Ophthalmol Vis Sci 55:3223–3230. https://doi.org/10.1167/iovs.14-14059
doi: 10.1167/iovs.14-14059 pubmed: 24781946
Ikuno Y, Kawaguchi K, Nouchi T, Yasuno Y (2010) Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci 51:2173–2176. https://doi.org/10.1167/iovs.09-4383
doi: 10.1167/iovs.09-4383 pubmed: 19892874

Auteurs

Ryo Mukai (R)

Department of Ophthalmology, Fukushima Medical University, 1 Hikarigaoka-Cho, Fukushima, 960-1295, Japan. ryohmukai@gmail.com.

Kanako Itagaki (K)

Department of Ophthalmology, Fukushima Medical University, 1 Hikarigaoka-Cho, Fukushima, 960-1295, Japan.

Jyunichiro Honjyo (J)

Department of Ophthalmology, Fukushima Medical University, 1 Hikarigaoka-Cho, Fukushima, 960-1295, Japan.

Hidetaka Matsumoto (H)

Department of Ophthalmology, Gunma University Graduate School of Medicine, Maebashi, Japan.

Tetsuju Sekiryu (T)

Department of Ophthalmology, Fukushima Medical University, 1 Hikarigaoka-Cho, Fukushima, 960-1295, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH